The National Agency for Food and Drug Administration and Control (NAFDAC) has expressed strong support for the recently signed Executive Order (EO) by President Bola Tinubu, asserting that it will pave the way for a sustainable and high-quality healthcare system in Nigeria. The agency believes that the EO addresses fundamental challenges and provides a clear direction for improving the pharmaceutical industry in the country.
In a statement issued by NAFDAC’s Director-General, Prof. Mojisola Adeyeye, on Saturday in Abuja, the agency commended President Tinubu for his commitment to transforming Nigeria’s health sector. Prof. Adeyeye highlighted that the reform and transformation agenda aimed at making NAFDAC a robust and stable regulatory body began six years ago when she took office. She emphasized that the EO would further enhance these efforts, ensuring that NAFDAC can effectively regulate and support the pharmaceutical industry, ultimately benefiting the health and well-being of Nigerians.
She added that the effort she put into transforming NAFDAC has started paying off, “part of which is what paved the way to signing of the Executive Order to make Nigeria to manufacture its own drugs.”
The Executive Order, she said, includes several measures such as Zero Tariff and Excise Duties which exempts specified pharmaceutical machinery, equipment, goods and accessories, as well as reduce production costs and make healthcare products affordable.
She noted that “the Executive Order also gives special waivers on pharmaceutical inputs like Active Pharmaceutical Ingredients (APIs) and other essential raw materials, including those for Long-lasting Insecticidal Nets (LLINs) and Rapid Diagnostic kits.”
She added that all these products would benefit from zero tariff, excise duties and Value Added Tax (VAT), as well as low prices of essential medicines and medical supplies.
Adeyeye explained that the Executive Order would also shape and establish framework contracts and volume to guarantee and stabilise local manufacturing of medical products.
According to her, it will also help in regulatory harmonisation, expedient approvals, develop harmonised implementation framework to guide regulatory agencies in streamlining approval processes.
She stated that the order would help in implementation and compliance, where agencies like Nigeria Customs Service, NAFDAC, Standard Organisation of Nigeria (SON) and Federal Inland Revenue Services (FIRS) would ensure swift implementation.
Adeyeye said “the waivers and exemptions are valid for two years. The order is vital to the success of the Nigeria Health Sector Renewal Investment Initiative (NHSRII) and will encourage local manufacturing, create jobs, stimulate economic growth and reduce dependence on imports.
“It will ensure reliable supply of essential healthcare products, enhance quality and innovation, strengthen health systems by address underinvestment and regulatory challenges.”
“The Executive Order will improve service delivery and health outcomes, and enhance resilience to future health crises.”
The NAFDAC boss noted that the President’s Executive Order underscores the administration’s commitment to transforming Nigeria’s health sector.
According to her, the Executive Order aligns with the broader objectives of the NHSRII and the )(NAFDAC) has said the Executive Order (EO) signed recently signed into law by President Bola Tinubu will set the stage for sustainable and high-quality healthcare system for Nigerians.
